Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 29 filings·Updated 20 Aug 2026
Showing 10 of 29 filings.
20 Aug 20261 filing
Company UpdateGeneral

Coastal Biotech secures incremental Ethanol allocation of 4,310 KL for EBPP ESY 2025-26

Incremental EBPP allocation

  • Coastal Biotech, a Coastal Corporation subsidiary, received incremental EBPP Ethanol allocation for ESY 2025-26.
  • The allocation is 4,310 KL to supply to BPCL, IOCL, and HPCL under EBPP across locations.
Filed 17:48View Source
8 Aug 20261 filing
Company UpdateGeneral

Coastal clarifies repayments were funded; bank-record dates reflect processing, not borrower delays

Bank repayment-date clarification

  • Context: clarification following a recent credit rating revision on repayments.
  • Funds for scheduled repayments were available; bank records reflect processing dates.
  • MTM/FCY movements and facility-level processing cause value-dating, not borrower delays.
  • May 31, 2025: EMI recovery for Cash Credit/OD; no borrower delay.
  • Dec 1, 2025: EMI recoveries for two loans completed; value-date Nov 30, 2025; no delay.
  • Mar 2, 2026: EMI recoveries for two loans completed; value-date Feb 28, 2026; no delay.
  • Apr 8, 2026 & May 7, 2026: recoveries completed after MTM/FCY delays; WC constraints resolved.
  • Overall account conduct satisfactory; no stress observed in facilities.
Filed 17:39View Source
7 Aug 20261 filing
Company UpdateCredit Rating

CARE downgrades Coastal Corporation's bank facilities to CARE D amid FY26 delays and performance

Rating action

  • Long-term bank facilities Rs 68.28 crore downgraded to CARE D from CARE BB.
  • Long-term/short-term facilities Rs 273.50 crore downgraded to CARE D / CARE D.

Rated facilities

  • Total facilities rated Rs 341.78 crore.
  • Long-term bank facilities and fund-based limits comprise the above totals.

Rationale

  • Downgrade due to FY26 operational and financial performance and delays in annual report.
  • Possible impact on credit profile cited by CARE Ratings.

Outlook / Change since last rating

  • Outlook not disclosed in action; prior rating had Stable outlook.
  • Change since last rating: Downgraded from CARE BB; prior outlook Stable.

Agency

  • Rating agency: CARE Ratings Limited (CareEdge Ratings).

Material changes

  • Downgrade from CARE BB to CARE D for both instruments.
Filed 17:58View Source
5 Aug 20262 filings
Company UpdateNewspaper Publication

Submission of Newspaper Advertisement of the 45th Annual General Meeting and e-voting of Coastal Corporation Limited

Filed 16:15View Source
Company UpdateCopy of Newspaper Publication

Coastal Corporation Limited has informed the Exchange about Copy of Newspaper Publication

Filed 16:15View Source
23 Jul 20261 filing
Board Meeting

Board meeting on 3 August 2026 to consider unaudited quarterly results for quarter ended 30 June 2026.

Meeting Details

  • Date: 3 August 2026; time and venue not disclosed.

Key Agenda Items

  • Un-Audited financial results for quarter ended 30 June 2026 to be considered.

Other Notes

  • Trading window closed from 1 July 2025; reopens 48 hours after the board meeting.
Filed 11:29View Source
7 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

No dematerialisation/rematerialisation requests received for the reporting period.

Dematerialisation status

  • No dematerialisation/rematerialisation requests were received during the reporting period.
Filed 13:03View Source
29 Jun 20261 filing
Insider Trading / SASTClosure of Trading Window

Coastal Corporation Ltd — Trading window closed from 1 July 2026 till 48 hours after the unaudited Q1 results for quarter ended 30 June 2026

Trading window

  • Trading window closed from 1 July 2026 until 48 hours after results for quarter ended 30 June 2026.
Filed 18:01View Source
16 Jun 20261 filing
Company UpdateInvestor Presentation

Coastal Corporation Ltd - 501831 - Announcement under Regulation 30 (LODR)-Investor Presentation

Business

  • Coastal Corporation processes and exports shrimp and value-added seafood products.
  • It also operates a grain-based ethanol business through subsidiary Coastal Biotech.

Operations

  • Seafood operations include Unit II and Unit III facilities in Andhra Pradesh.
  • Ethanol plant capacity is 198 KLPD in Odisha.

Financials

  • Seafood business revenue was Rs 728.75 crore, with EBITDA of Rs 35.31 crore.
  • Seafood EBITDA margin was 4.85%; PBT was Rs 17.36 crore.
  • Ethanol business revenue was Rs 241.90 crore, with EBITDA of Rs 25.16 crore.
  • Ethanol EBITDA margin was 10.40%; PBT was Rs 17.49 crore.

Leadership

  • Mr. G.V.V. Satyanarayana is Director-Finance and CFO.
  • Dr. E. Sankara Rao is Chairman and Independent Director.
  • Mr. Valsaraj Thottoli is Founder, Vice Chairman and Managing Director.
Filed 11:36View Source
1 Jun 20261 filing
Company UpdateNewspaper Publication

Newspaper publication of Audited Financial Results for the quarter and year ended 31.03.2026

Filed 12:27View Source
Showing 10 of 29 filings